Identifying barriers to the availability and use of Magnesium Sulphate Injection in resource poor countries: A case study in Zambia
<p>Abstract</p> <p>Background</p> <p>Pre-eclampsia and eclampsia are serious complications of pregnancy and major causes of maternal mortality and morbidity worldwide. According to systematic reviews and WHO guidelines magnesium sulphate injection (MgSO4) should be the...
Saved in:
Main Authors: | Hill Suzanne R (Author), Bero Lisa A (Author), Ridge Anna L (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2010-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Availability and use of magnesium sulphate at health care facilities in two selected districts of North Karnataka, India
by: Geetanjali Katageri, et al.
Published: (2018) -
School-Age Outcomes of Antenatal Magnesium Sulphate in Preterm Infants
by: Akira Kobayashi, et al.
Published: (2023) -
Translating research into policy and practice in developing countries: a case study of magnesium sulphate for pre-eclampsia
by: Trommald Mari, et al.
Published: (2005) -
Barriers and facilitators to the quality use of essential medicines for maternal health in low-resource countries: An Ishikawa framework
by: Dan N. Tran, et al.
Published: (2015) -
Antenatal magnesium sulphate administration for fetal neuroprotection: a French national survey
by: Clément Chollat, et al.
Published: (2017)